Holleykin Pharmaceutical

Holleykin Pharmaceutical, a subsidiary of the Holley Group, is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of anti-malarial drugs. The company is a global leader in the production of artemisinin and its derivatives, providing high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Holleykin's flagship product, Artekin (a combination of dihydroartemisinin and piperaquine), was developed through a landmark partnership with the Medicines for Malaria Venture (MMV) and the University of Oxford. Beyond its anti-malarial core, the company produces a variety of other pharmaceuticals, including antibiotics and cardiovascular medications. Holleykin plays a vital role in global health initiatives, particularly in Africa and Southeast Asia, where it supplies affordable, life-saving treatments.